Lung cancer combo trial halted early – only 10 patients enrolled
Disease control
Terminated
This study tested a new drug (hSTC810) combined with standard chemotherapy (paclitaxel) in 10 adults with advanced small cell lung cancer that had returned or stopped responding to initial treatment. The goal was to see if the combination was safe and could shrink tumors or delay…
Phase: PHASE1, PHASE2 • Sponsor: STCube, Inc. • Aim: Disease control
Last updated May 14, 2026 12:05 UTC